How a biopharmaceutical company evaluated social media to monitor off-label drug use Cortical.io Message Intelligence Case Study The Challenge The prescribing of medications in a manner not specified by the FDA – known as off-label use – is widespread: according to a 2014 US study, it accounts for 10 to 20 percent of all prescriptions written. However, its exact extent is difficult to measure because pharmaceutical companies have no direct feedback mechanism to track what medical conditions their products are prescribed for. However, being aware of how the medications they produce are used is of high importance for regulatory purposes as well as general pharmacovigilance activities. Since pharmaceutical companies do not sell directly to consumers, they have no means to monitor how

Join for free to read